Mannatech Inc., a company operating within the Consumer Staples sector and specializing in the Personal Care Products industry, has recently experienced a notable decline in its stock price during pre-market trading. The company, which is based in the United States, focuses on the development and sale of proprietary nutritional supplements and topical products. These products are distributed through a network of independent distributors and are characterized by the inclusion of an ambrotose complex, derived from naturally occurring sugars.
As of May 12, 2026, Mannatech’s stock closed at $5.2, marking a significant drop from its 52-week high of $12.45, achieved on November 2, 2025. The stock’s recent performance has brought it closer to its 52-week low of $4.28, recorded on April 28, 2026. This decline in stock value is part of a broader market trend where several companies experienced significant price movements, with Mannatech’s reduction being particularly pronounced.
Mannatech Inc. is listed on the Nasdaq, and its market capitalization stands at $9,440,000 USD. The company’s financial metrics reveal a price-to-earnings ratio of -0.6, indicating that it is currently not generating positive earnings. This financial situation may contribute to investor caution and the observed volatility in its stock price.
The company’s product offerings are available in the United States, Canada, and Australia, reflecting its international market presence. Despite the recent downturn in its stock price, no additional commentary on Mannatech’s fundamentals or any forthcoming announcements was provided in the source material. Investors and stakeholders may be closely monitoring the company’s future developments and market strategies to assess potential recovery or growth opportunities.
